UK’s Real-World Evidence Expectations Still Not Clear To Industry
Executive Summary
Medtech companies looking to gain reimbursement for digital products in the UK are hindered by a confusing funding system and unclear real-world evidence requirements, but improvements should be easy to implement, trade association ABHI says.